Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) EBT Margin (2018 - 2025)

Historic EBT Margin for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to 16.01%.

  • TransMedics' EBT Margin rose 121100.0% to 16.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.4%, marking a year-over-year increase of 83500.0%. This contributed to the annual value of 8.1% for FY2024, which is 192900.0% up from last year.
  • As of Q3 2025, TransMedics' EBT Margin stood at 16.01%, which was up 121100.0% from 22.99% recorded in Q2 2025.
  • TransMedics' EBT Margin's 5-year high stood at 22.99% during Q2 2025, with a 5-year trough of 239.29% in Q3 2021.
  • Its 5-year average for EBT Margin is 39.1%, with a median of 6.32% in 2023.
  • Per our database at Business Quant, TransMedics' EBT Margin crashed by -1755500bps in 2021 and then soared by 2104500bps in 2022.
  • TransMedics' EBT Margin (Quarter) stood at 149.71% in 2021, then surged by 85bps to 22.16% in 2022, then surged by 119bps to 4.31% in 2023, then skyrocketed by 33bps to 5.75% in 2024, then soared by 179bps to 16.01% in 2025.
  • Its EBT Margin was 16.01% in Q3 2025, compared to 22.99% in Q2 2025 and 18.58% in Q1 2025.